![Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - ScienceDirect Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283819308231-gr4.jpg)
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation - ScienceDirect
![Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org](https://prod-images-static.radiopaedia.org/images/51527043/b95858208c2202e13e2cf80b5682a8_gallery.jpeg)
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
![Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology](https://www.auajournals.org/cms/asset/472738d8-800f-4e0f-beec-1b864edf6d9e/abs-fig.jpg)
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
![MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology](https://cdn.amegroups.cn/journals/amepc/files/journals/3/articles/18050/public/18050-PB8-R1.png/w300)
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
![Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer | Scientific Reports Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-72544-z/MediaObjects/41598_2020_72544_Fig5_HTML.jpg)
Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer | Scientific Reports
![JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies](https://pub.mdpi-res.com/jpm/jpm-10-00270/article_deploy/html/images/jpm-10-00270-ag-550.jpg?1607589479)
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
![PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1078143920305792-gr1.jpg)
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
![Frontiers | Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process Frontiers | Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process](https://www.frontiersin.org/files/Articles/1092073/fonc-13-1092073-HTML/image_m/fonc-13-1092073-g001.jpg)
Frontiers | Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process
![PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract](https://www.urotoday.com/images/pirads-3_graphical_abstract.png)
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
![Diagnostics | Free Full-Text | Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with Diagnostics | Free Full-Text | Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with](https://www.mdpi.com/diagnostics/diagnostics-11-01335/article_deploy/html/images/diagnostics-11-01335-g001.png)
Diagnostics | Free Full-Text | Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with
![Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer | BMC Urology | Full Text Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-021-00928-y/MediaObjects/12894_2021_928_Fig1_HTML.png)
Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer | BMC Urology | Full Text
![In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43055-021-00543-9/MediaObjects/43055_2021_543_Fig2_HTML.png)
In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? | Egyptian Journal of Radiology and Nuclear Medicine | Full Text
![MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology](https://cdn.amegroups.cn/journals/amepc/files/journals/3/articles/18050/public/18050-PB3-R1.png/w300)
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
![Upgrading an equivocal lesion in the peripheral zone (PI-RADS 3) to a... | Download Scientific Diagram Upgrading an equivocal lesion in the peripheral zone (PI-RADS 3) to a... | Download Scientific Diagram](https://www.researchgate.net/publication/306090189/figure/fig3/AS:394606630981675@1471092960912/Upgrading-an-equivocal-lesion-in-the-peripheral-zone-PI-RADS-3-to-a-significant-lesion.png)
Upgrading an equivocal lesion in the peripheral zone (PI-RADS 3) to a... | Download Scientific Diagram
![Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-10859-9/MediaObjects/41598_2022_10859_Fig1_HTML.png)
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate | Scientific Reports
![Systematic Biopsy of the Prostate Can Be Omitted in Men With PI-RADS™ 5 and PSA Density >15 | PracticeUpdate Systematic Biopsy of the Prostate Can Be Omitted in Men With PI-RADS™ 5 and PSA Density >15 | PracticeUpdate](https://d2ogjlfjkptkow.cloudfront.net/contentimage/31550.jpg)
Systematic Biopsy of the Prostate Can Be Omitted in Men With PI-RADS™ 5 and PSA Density >15 | PracticeUpdate
![Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80749-5/MediaObjects/41598_2020_80749_Fig1_HTML.png)
Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports
![PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract](https://www.urotoday.com/images/PIRADS-3_figure_3.png)